PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.

Autor:	Kam CS; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Ho DW; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Ming VS; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Tian L; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Sze KM; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Zhang VX; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Tsui YM; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Husain A; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Lee JM; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Wong CC; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam., Chan AC; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam; Department of Surgery, The University of Hong Kong, Hong Kong, Pokfulam., Cheung TT; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam; Department of Surgery, The University of Hong Kong, Hong Kong, Pokfulam., Chan LK; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam. Electronic address: lokongchan@gmail.com., Ng IO; Department of Pathology, The University of Hong Kong, Hong Kong, Pokfulam; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, Pokfulam. Electronic address: iolng@hku.hk.
Jazyk:	angličtina
Zdroj:	Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2023; Vol. 15 (6), pp. 1325-1350. Date of Electronic Publication: 2023 Feb 16.
DOI:	10.1016/j.jcmgh.2023.02.004
Abstrakt:	Background & Aims: Metabolic reprogramming is recognized as a cancer hallmark intimately linked to tumor hypoxia, which supports rapid tumor growth and mitigates the consequential oxidative stress. Phosphofructokinase-fructose bisphosphatase (PFKFB) is a family of bidirectional glycolytic enzymes possessing both kinase and phosphatase functions and has emerged as important oncogene in multiple types of cancer. However, its clinical relevance, functional significance, and underlying mechanistic insights in hepatocellular carcinoma (HCC), the primary malignancy that develops in the most important metabolic organ, has never been addressed. Methods: PFKFB4 expression was examined by RNA sequencing in The Cancer Genome Atlas and our in-house HCC cohort. The up-regulation of PFKFB4 expression was confirmed further by quantitative polymerase chain reaction in an expanded hepatitis B virus-associated HCC cohort followed by clinicopathologic correlation analysis. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-mediated PFKFB4 knockout cells were generated for functional characterization in vivo, targeted metabolomic profiling, as well as RNA sequencing analysis to comprehensively examine the impact of PFKFB4 loss in HCC. Results: PFKFB4 expression was up-regulated significantly in HCC and correlated positively with TP53 and TSC2 loss-of-function mutations. In silico transcriptome-based analysis further revealed PFKFB4 functions as a critical hypoxia-inducible gene. Clinically, PFKFB4 up-regulation was associated with more aggressive tumor behavior. Functionally, CRISPR/Cas9-mediated PFKFB4 knockout significantly impaired in vivo HCC development. Targeted metabolomic profiling revealed that PFKFB4 functions as a phosphatase in HCC and its ablation caused an accumulation of metabolites in downstream glycolysis and the pentose phosphate pathway. In addition, PFKFB4 loss induced hypoxia-responsive genes in glycolysis and reactive oxygen species detoxification. Conversely, ectopic PFKFB4 expression conferred sorafenib resistance. Conclusions: PFKFB4 up-regulation supports HCC development and shows therapeutic implications. (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu